Gastric bypass versus sleeve gastrectomy in type 2 diabetes: effects on hepatic steatosis and fibrosis. A randomized controlled trial
Seeberg KA, Borgeraas H, Hofsø D, et al.
Ann Intern Med. 2022;175(1):74-83
Leggi
Breaking news
Empagliflozin, health status, and quality of life in patients with heart failure and preserved ejection fraction: the EMPEROR-Preserved trial
Butler J, Filippatos G, Siddiqi TJ, et al.
Circulation. 2022;145(3):184-193
Leggi
Serial assessment of high-sensitivity cardiac troponin and the effect of dapagliflozin in patients with heart failure with reduced ejection fraction: an analysis of the DAPA-HF trial
Berg DD, Docherty KF, Sattar N, et al.
Circulation. 2022;145(3):158-169
Leggi
Risk for newly diagnosed diabetes >30 Days After SARS-CoV-2 infection among persons aged <18 years - United States, March 1, 2020-June 28, 2021
Barrett CE, Koyama AK, Alvarez P, et al.
MMWR Morb Mortal Wkly Rep. 2022;71(2):59-65.
Leggi
NOTA AIFA 100 – Prescrizione degli inibitori del SGLT2, degli agonisti recettoriali del GLP1, degli inibitori del DPP4 e loro associazioni nel trattamento del diabete mellito tipo 2
25 gennaio 2022
Leggi
Sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4 inhibitors, and risk of hospitalization
Lyu B, Grams ME, Chang A, et al.
Am J Cardiol. 2022;165:124-130.
Leggi
Glycemic outcomes in baseline hemoglobin a1c subgroups in the International Diabetes Closed-Loop (iDCL) Trial
Ekhlaspour L, Town MA, Raghinaru D, et al.
Diabetes Technol Ther. Pub. online 12 January 2022
Leggi
Risk factor analysis for type 2 diabetic patients about hypoglycemia using continuous glucose monitoring: Results from a prospective observational study
Uemura F, Okada Y, Mita T, et al.
Diabetes Technol Ther. Pub. online 20 January 2022.
Leggi
Outcomes of patients with diabetes versus patients without diabetes hospitalized with acute heart failure
Wan SH, Slusser JP, Hodge DO, Chen HH
Am J Cardiol. 2022;165:65-71
Leggi
Predictors of cardio-kidney complications and treatment failure in patients with chronic kidney disease and type 2 diabetes treated with SGLT2 inhibitors
Kovesdy C , Schmedt N, Folkerts K, et al.
BMC Med. 2022;20(1):2
Leggi